Position in RPRX
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$74,066,541
+$71,825,500 QoQ
Shares Held
1,544,018
+2562.2% QoQ
Ownership
0.268%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $961,918,485 across 122 Biotechnology names. RPRX ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
655,443 | $292,681,510 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
323,338 | $249,823,869 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
1,544,018 | $74,066,541 | |
| 4 | INCY |
Incyte Corp
|
582,368 | $54,812,474 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
89,619 | $29,652,235 | |
| 6 | MRNA |
Moderna, Inc.
|
490,088 | $24,896,468 | |
| 7 | INSM |
INSMED Inc
|
116,456 | $19,042,883 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
227,059 | $15,469,528 |
All Filings in RPRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,066,541 | 1,544,018 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $2,241,041 | 57,998 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $8,456,898 | 239,708 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,307,889 | 36,300 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,542,531 | 113,798 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,395,781 | 172,316 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,732,119 | 202,620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,839,345 | 524,814 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $28,075,030 | 924,433 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,080,634 | 145,270 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $3,646,991 | 134,377 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,079,044 | 132,695 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $904,497 | 25,104 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $30,634,995 | 775,177 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $18,745,014 | 466,526 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,837,023 | 233,992 | Shares | Defined | 2022-08-11 | |
| 2021-09-30 | $945,566 | 26,164 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $694,657 | 16,947 | Shares | Defined | 2021-08-13 | |
| 2020-12-31 | $917,967 | 18,341 | Shares | Defined | 2021-02-25 | |
| 2020-09-30 | $253,850 | 6,034 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||